Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder of the lung, and one that affects 2.6 million Canadians and 380 million people worldwide. Although the disease affects a large population worldwide the therapies used for treatment remain imprecise. With the lack of disease modifying therapies there is a pressing need to discover novel targets to promote new therapeutic discoveries and ultimately improve the care and health outcomes of patients with COPD. To date, the discovery of novel therapeutics has been greatly hindered by outdated cell models and costly animal models. Our group proposes that through collaboration between engineers, pharmacologists, biologists and physicians we can leverage Organs-on-chips (OOC) technology to discover and validate novel COPD therapeutic targets. Organs-on-chips are miniature devices mimicking aspects of the in vivo conditions of human organs. What we propose to do in this project is to build upon a previously developed airway-on-a-chip technology to better mimic the human airways.
Karen Cheung
Sayyed Soroush Nasseri
Providence Health Care
Engineering - biomedical
Medical devices
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.